Genomic sequencing has already made a substantial impact on both biological and medical research. Next generation, rapid, low-cost genome sequencing promises
to address a broad range of genetic analysis applications including: comparative genomics, high-throughput SNP detection, sequencing to analyze small
RNAs, identifying mutant genes in disease pathways, profiling transcriptomes for organisms where little information is available, and researching lowly
expressed genes. These discoveries will shed new light on the biological pathways involved in human health and disease, which in turn will lead to better strategies
for diagnosis, treatment and prevention. Rapid sequencing is going to play a major role in bringing the promise of personalized healthcare closer to reality.
Cambridge Healthtech Institute’s Inaugural Next Generation Sequencing: Applications and Case Studies provides and unparalleled opportunity to capitalize
on the next generation of high-throughput sequencing technologies.
| A Must Attend
for those Working on: |
De novo sequencing • Resequencing •
Deep sequencing • Mutation/heterozygote detection • Comparative genomics • Metagenomics
SNP genotyping • Small RNA sequencing • Relative fluorescent quantitation
Microsatellite analysis • Transcription profiling • AFLP® analysis • Methylation analysis •
T-RFLP analysis • MLST • BAC fingerprinting SAGE™
TECHNOLOGY BLAST!
Explore available genomic screening platforms as presented by sequencing leaders. An unparalleled opportunity to compare and contrast these next generation sequencing platforms to best suit your research needs.
ROUNDTABLE
DISCUSSION:
The $1000 Genome: Are We There Yet?
Host: Kevin Davies, Ph.D., Editor-in-Chief, BioIT World
Over the past few years, exciting advances in next-generation sequencing technology
have seen the production of commercial instruments capable of profound
improvements in sequence throughput and economy. Early applications include
cancer genome analysis, microbial genomics, and the study of the Neanderthal
genome. Competition in the field is increasingly intense, with start-ups vying
with established life science instrument makers to provide the gold-standard
technology that will drive us towards the threshold of the "$1000 genome.”
The expert panelists in this roundtable will review the current state of
next-
generation sequencing technologies and look ahead to new applications in science and
medicine as well as highlight the many challenges that lay in store.
FEATURED SPEAKERS:
Applications of High-Throughput Mass Spectrometry
Charles R. Cantor, Ph.D., CSO, Sequenom, Inc.
Title to be determined
Richard Gibbs, Ph.D., Director, Human Genome Sequencing Center, Baylor College of Medicine (invited)
For more
information on exhibiting or sponsoring, contact:
David Karp at 781-972-5483 or dkarp@healthtech.com
|
